Score Your Stock

YSPSAH Y.S.P. SOUTHEAST ASIA HOLDING BERHAD

7178.KL · Health Care · Pharmaceuticals
Top 12% of scored stocks
Compare with nearby peers
OkayTop 12% of scored stocks
ShariahLow-Price Yield

YSPSAH scores 74/100 on fundamentals: in the top 12% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (100/100); its weakest is Business Strength (40/100). It carries 1 warning flag: Low-Price Yield.

Best
Financial 100
Weakest
Business 40
  • Carries a Low-Price Yield flag
Mkt capRM 276.6m#444 of 1113 in BursaEPSRM 0.19P/E10.2×✓ vs sector avg 27×P/B0.7×✓ vs sector avg 1.8×Div yield6%✓ Top 12% in Bursa52w range · 14% of range1.912.20
as of 18 Oct 2026

Nearby peers

Ranks #3 of 30 in Health Care by score

#1DPHARMA85#2KOSSAN76
#3YSPSAH74
#4NOVA73#5HARTA68#6PMCK67

One-Minute Summary

Why YSPSAH scores 74

A financially strong, inexpensively priced stock, but business strength needs attention.

What looks good
What to watch

After Jun '26 results: 71 → 75+4· Quarterly Momentum Okay → StrongSee all movers →

Business StrengthLowest pillar

40
Why 40?
Pillar score: (0 + 1 + 0 + 1 + 2) = 4 of 10 points → 40
Return on Equity (ROE)6%Weak4-Year Revenue Growth+1%/yrOkay4-Year Profit Growth-10%/yrWeakNet Profit Margin7%OkayQuarterly Momentum+2%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -27.6%Equity ↑ +7.3%ROE % 6.4%
Net ProfitEquityROE %
37m27m25m27m395m409m418m424m202320242025TTM9.4%6.5%6%6.4%

Revenue & Net Profit, with Net Margin

Revenue ↑ +4.1%Net Profit ↓ -27.6%Net Margin % 7.3%
RevenueNet ProfitNet Margin %
355m369m365m370m37m27m25m27m202320242025TTM10.5%7.2%6.8%7.3%

Sales have been roughly flat for 4 years: the business isn't really growing, just maintaining.

Profit fell about 27.6% from where it was 4 years ago: the boom has cooled off.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↓ -6.2%Net Profit ↑ +22.9%Net Margin % 5.3%
RevenueNet ProfitNet Margin %
87m97m103m75m92m95m101m82m4m6m11m1m6m7m10m4mSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '264%6.4%10.8%0.9%6.6%7.4%9.5%5.3%
▼▼▼▼▲▲▼▲

Sales have stayed roughly flat over the last 8 quarters.

Profit grew about 22.9% over the last 8 quarters: the business is keeping more of what it earns.

Why 100?
Pillar score: (2 + 2 + 2) = 6 of 6 points → 100
Debt-to-Equity0.1×StrongCurrent Ratio4.4×StrongInterest Coverage16.1×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -8.1%Equity ↑ +7.3%D/E 0.1×
Total DebtEquityD/E
53m53m51m49m395m409m418m424m202320242025TTM0.1×0.1×0.1×0.1×

Borrowings have stayed roughly level: manageable, as long as profits stay healthy.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +11.8%Current Liabilities ↑ +30.4%Current Ratio 4.4×
Current AssetsCurrent LiabilitiesCurrent Ratio
354m358m373m395m69m63m71m89m202320242025TTM5.2×5.7×5.3×4.4×
Why 88?
Pillar score: (1 + 2 + 2 + 2) = 7 of 8 points → 88
Dividend Quality6%Okay
Payout ratio: 58%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +47.7%Free CF ↑ +7,733.3%
Operating CFFree CF
36m50m55m54m1m41m52m47m202320242025TTM

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↑ +23.5%Short-Term Debt ↓ -10.3%Total Debt ↓ -8.1%
CashShort-Term DebtTotal Debt
130m139m148m161m9m8m8m8m53m53m51m49m202320242025TTM

Dividends per Share, with Yield

DPS (sen) ↑ +87.5%Yield % 5.6%
DPS (sen)Yield %
810111520222023202420254.8%4.8%5%5.6%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 67?
Pillar score: (2 + 2 + 0) = 4 of 6 points → 67
P/E Ratio10.2×StrongP/B Ratio0.7×StrongPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 2.13RM 2.03RM 1.93100500Oct '25Feb '26Jun '26Oct '26💰💰

The share price has been roughly flat over the past year.

What happened, and how the price moved

  • 26 Jun 2026Ex-dividend 7.0 sen a share3.5% yield at that priceWeek▲1.9%KLCI −2.6%Month▲1.9%KLCI +1.1%
  • 12 Dec 2025Ex-dividend 4.0 sen a share2.0% yield at that priceWeek▲1.5%KLCI +1.3%Month▲1.0%KLCI +3.3%
Why 75?
Pillar score: (1 + 1 + 2 + 2 + 1 + 2) = 9 of 12 points → 75
Earnings ConsistencyUnevenOkayDebt Trend (4yr)StableOkayShare Count Trend (4yr)+0%/yrStrongInventory vs Sales (4yr)-4.4 pp/yr vs salesStrongAsset Turnover Trend (4yr)-3.9%OkayQuarterly Consistency1 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +4.1%Inventory ↓ -9%Inv. % of Rev. 32.4%
RevenueInventoryInv. % of Rev.
355m369m365m370m131m126m121m120m202320242025TTM37%34.3%33.1%32.4%

Get an email when YSPSAH's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #3 of 30 in Health Care by score

Sector peers

#1DPHARMA85#2KOSSAN76
#3YSPSAH (you)74
#4NOVA73#5HARTA68#6PMCK67

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026RM 369.5mRM 27.0mRM 53.6mRM 47.0mRM -6.5mRM 160.9mRM 48.8mRM 7.8mRM 424.1mRM 395.4mRM 89.3mRM 563.9mRM 131.7mRM 119.6m-6%7%0.1×4.4×16.1×58%----
2025RM 365.1mRM 25.0mRM 55.0mRM 51.5mRM -3.5mRM 148.1mRM 50.8mRM 8.3mRM 417.9mRM 373.4mRM 70.9mRM 541.1mRM 115.4mRM 120.8mRM 15.0m6%7%0.1×5.3×15.0×85%7%11.4×0.7×-
2024RM 368.7mRM 26.7mRM 49.7mRM 40.6mRM -9.1mRM 138.9mRM 53.3mRM 8.3mRM 409.0mRM 357.8mRM 62.8mRM 528.7mRM 113.1mRM 126.4mRM 11.0m7%7%0.1×5.7×15.3×58%5%10.9×0.7×-
2023RM 355.0mRM 37.3mRM 36.3mRM 0.6mRM -35.8mRM 130.3mRM 53.1mRM 8.7mRM 395.1mRM 353.7mRM 68.5mRM 520.7mRM 119.5mRM 131.4mRM 10.0m9%11%0.1×5.2×24.8×38%5%7.6×0.7×0.9